Pain Therapeutics Company Profile (NASDAQ:PTIE)

About Pain Therapeutics

Pain Therapeutics logoPain Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on drug development efforts on disorders of the nervous system, such as chronic pain. The Company's lead drug candidate, REMOXY, is an abuse-deterrent, oral formulation of oxycodone (CII). The Company's other products is FENROCK. REMOXY is a painkiller with a formulation designed to reduce potential risks of unintended use. The Company has developed REMOXY to make oxycodone difficult to abuse yet provide approximately 12 hours of steady pain relief when used by patients. REMOXY is intended to meet the needs of healthcare prescribing opioid drugs and seeking to minimize the risks of drug diversion, abuse or accidental patient misuse. The Company's drug candidate FENROCK is an abuse-deterrent transdermal pain patch in the pre-Investigational new drug-stage of development. FENROCK is designed to provide pain relief over 72 hours.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Pharmaceuticals
  • Exchange: NASDAQ
  • Symbol: PTIE
  • CUSIP: 69562K10
Key Metrics:
  • Previous Close: $2.73
  • 50 Day Moving Average: $2.50
  • 200 Day Moving Average: $2.33
  • 52-Week Range: $46,141,000.00 - $1.55
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -5.25
  • P/E Growth: -0.07
  • Market Cap: $125.96M
  • Outstanding Shares: 46,141,000
  • Beta: 1.31
Profitability:
  • Return on Equity: -61.43%
  • Return on Assets: -56.14%
Debt:
  • Current Ratio: 12.69%
  • Quick Ratio: 12.69%
Additional Links:
Companies Related to Pain Therapeutics:

Analyst Ratings

Consensus Ratings for Pain Therapeutics (NASDAQ:PTIE) (?)
Ratings Breakdown: 1 Hold Rating
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $2.50 (8.42% downside)

Analysts' Ratings History for Pain Therapeutics (NASDAQ:PTIE)
Show:
DateFirmActionRatingPrice TargetDetails
9/13/2016GabelliDowngradeBuy -> Hold$2.50View Rating Details
(Data available from 9/25/2014 forward)

Earnings

Earnings History for Pain Therapeutics (NASDAQ:PTIE)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/7/2016        
7/19/2016Q216($0.14)($0.07)ViewN/AView Earnings Details
5/5/2016Q1($0.10)($0.13)ViewN/AView Earnings Details
10/30/2014Q314($0.08)$89.70 millionViewN/AView Earnings Details
8/5/2014Q214($0.07)ViewN/AView Earnings Details
5/6/2014Q1 14($0.06)($0.08)$1.96 millionViewN/AView Earnings Details
2/4/2014Q413($0.01)$0.72$2.00 million$35.24 millionViewN/AView Earnings Details
10/31/2013Q313($0.01)($0.02)$2.00 million$1.96 millionViewN/AView Earnings Details
4/24/2013Q1 2013($0.01)($0.01)$2.80 million$1.96 millionViewN/AView Earnings Details
2/6/2013Q4 2012($0.02)($0.08)$2.79 million$2.47 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Pain Therapeutics (NASDAQ:PTIE)
Current Year EPS Consensus Estimate: $-0.46 EPS
Next Year EPS Consensus Estimate: $-0.52 EPS

Dividends

Dividend History for Pain Therapeutics (NASDAQ:PTIE)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
12/11/2012special$0.7512/13/201212/17/201212/24/2012
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Pain Therapeutics (NASDAQ:PTIE)
Insider Ownership Percentage: 32.40%
Institutional Ownership Percentage: 55.07%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/6/2013Sanford RobertsonDirectorBuy50,000$3.73$186,500.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Pain Therapeutics (NASDAQ:PTIE)
DateHeadline
News IconKeen Investors Find News on Pain Therapeutics Inc. (NASDAQ:PTIE) - Duncan Research (NASDAQ:PTIE)
www.duncanindependent.com - September 24 at 11:17 AM
News IconBiotech news that matter for investors: Pain Therapeutics Inc. (NASDAQ:PTIE), Peregrine Pharmaceuticals, Inc ... - The Voice Registrar (NASDAQ:PTIE)
voiceregistrar.com - September 23 at 11:39 AM
nasdaq.com logoWill Pain Therapeutics (PTIE) Continue to Surge Higher? - Nasdaq (NASDAQ:PTIE)
www.nasdaq.com - September 23 at 11:39 AM
finance.yahoo.com logoWill Pain Therapeutics (PTIE) Continue to Surge Higher? (NASDAQ:PTIE)
finance.yahoo.com - September 23 at 11:39 AM
News IconBiotech news that matter for investors: Pain Therapeutics Inc. (NASDAQ:PTIE), Aegerion Pharmaceuticals, Inc ... - The Voice Registrar (NASDAQ:PTIE)
voiceregistrar.com - September 21 at 6:30 PM
News IconPenny Stock Investors Take an Interest in Pain Therapeutics Inc. (NASDAQ:PTIE) - Duncan Research (NASDAQ:PTIE)
www.duncanindependent.com - September 21 at 10:57 AM
benzinga.com logoMid-Afternoon Market Update: Ascena Retail Drops On Earnings Miss; DTS Shares Spike Higher - Benzinga (NASDAQ:PTIE)
www.benzinga.com - September 21 at 10:57 AM
News IconShares Observed Gapping Up Before Market Open: Pain Therapeutics Inc. (NASDAQ:PTIE) - Post News (NASDAQ:PTIE)
www.kentuckypostnews.com - September 19 at 6:50 PM
News IconUnder the Microscope: Getting a Closer Look at Shares of Pain Therapeutics Inc. (NASDAQ:PTIE) - Duncan Research (NASDAQ:PTIE)
www.duncanindependent.com - September 19 at 6:50 PM
finance.yahoo.com logoPain Therapeutics downgraded by Gabelli & Co (NASDAQ:PTIE)
finance.yahoo.com - September 13 at 11:48 AM
News IconThree Shots on Goal in Q4/16 for DURECT Corp. (NASDAQ:PTIE)
www.investorideas.com - September 8 at 6:38 PM
finance.yahoo.com logoPain Therapeutics (PTIE) Worth a Look: Stock Gains 7.6% (NASDAQ:PTIE)
finance.yahoo.com - July 22 at 8:45 AM
seekingalpha.com logoPain Therapeutics net loss improves by 12% in Q2 (NASDAQ:PTIE)
seekingalpha.com - July 20 at 7:50 PM
streetinsider.com logoPain Therapeutics (PTIE) Reports Q2 Loss of $0.07/Share (NASDAQ:PTIE)
www.streetinsider.com - July 20 at 9:48 AM
4-traders.com logoPain Therapeutics Reports Q2 2016 Financial Results (NASDAQ:PTIE)
www.4-traders.com - July 19 at 7:06 PM
sg.finance.yahoo.com logoPain Therapeutics reports 2Q loss (NASDAQ:PTIE)
sg.finance.yahoo.com - July 19 at 5:07 PM
investopedia.com logoTop 3 Biotech Companies Awaiting FDA Approval (PTIE,DRRX,PGNX) (NASDAQ:PTIE)
www.investopedia.com - July 12 at 11:21 AM
fxpips.com logoStocks Gapping Down Today – CAPR, SBSA, NBN, VRAY, SKIS, PTI, OXFD (NASDAQ:PTIE)
www.fxpips.com - July 7 at 9:48 AM
streetinsider.com logoNear Term Approval of Durect (DRRX) REMOXY Likely as FDA Panel Deemed Unnecessary - Rodman & Renshaw (NASDAQ:PTIE)
www.streetinsider.com - July 6 at 11:36 AM
News IconIs Pain Therapeutics, Inc. (PTIE) And Remoxy’s Long And Winding Road Nearing An End? (NASDAQ:PTIE)
feedproxy.google.com - July 5 at 12:46 PM
marketexclusive.com logoIs Pain Therapeutics, Inc. (NASDAQ:PTIE) And Remoxy’s Long And Winding Road Nearing An End? (NASDAQ:PTIE)
marketexclusive.com - July 4 at 6:09 PM
publicnow.com logoPain Therapeutics Announces Advisory Committee Meeting for REMOXY® Is Not Needed (NASDAQ:PTIE)
www.publicnow.com - July 1 at 9:21 AM
biz.yahoo.com logoPAIN THERAPEUTICS INC Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:PTIE)
biz.yahoo.com - June 29 at 4:11 PM
capitalcube.com logoPain Therapeutics, Inc. :PTIE-US: Earnings Analysis: Q1, 2016 By the Numbers : June 8, 2016 (NASDAQ:PTIE)
www.capitalcube.com - June 8 at 6:05 PM
News IconPain Therapeutics Incorporated (NASDAQ:PTIE) Short Interest Increased By 43.28% - HNN (NASDAQ:PTIE)
hintsnewsnetwork.com - May 29 at 10:07 PM
investingnews.com logoPain Therapeutics Announces FDA Advisory Committee Meeting for REMOXY® - Investing News Network (press release) (registration) (blog) (NASDAQ:PTIE)
investingnews.com - May 20 at 5:05 PM
globenewswire.com logoPain Therapeutics Announces FDA Advisory Committee Meeting for REMOXY® - GlobeNewswire (press release) (NASDAQ:PTIE)
globenewswire.com - May 19 at 5:08 PM
publicnow.com logoPain Therapeutics Announces FDA Advisory Committee Meeting for REMOXY® (NASDAQ:PTIE)
www.publicnow.com - May 19 at 9:12 AM
finance.yahoo.com logoDURECT Announces FDA Advisory Committee Meeting for REMOXY® (NASDAQ:PTIE)
finance.yahoo.com - May 19 at 9:05 AM
News IconPain Therapeutics Incorporated (NASDAQ:PTIE) Sellers Increased By 13.84% Their Shorts - Wall Street Hints and News (NASDAQ:PTIE)
hintsnewsnetwork.com - May 17 at 8:53 AM
News IconHC Stocks Judgment: Rosetta Genomics Ltd. (ROSG), Pain Therapeutics Inc. (PTIE), MediciNova Inc. (MNOV) - share market updates (press release) (NASDAQ:PTIE)
sharemarketupdates.com - May 16 at 10:05 AM
biz.yahoo.com logoPAIN THERAPEUTICS INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders (NASDAQ:PTIE)
biz.yahoo.com - May 12 at 4:48 PM
nasdaq.com logoPain Therapeutics to Present New REMOXY Data At American Pain Society Meeting - Nasdaq (NASDAQ:PTIE)
www.nasdaq.com - May 11 at 5:33 PM
finance.yahoo.com logoPain Therapeutics to Present New REMOXY Data At American Pain Society Meeting (NASDAQ:PTIE)
finance.yahoo.com - May 11 at 9:05 AM
finance.yahoo.com logoDURECT Announces New REMOXY® Data being Presented at American Pain Society Meeting (NASDAQ:PTIE)
finance.yahoo.com - May 11 at 9:05 AM
finance.yahoo.com logoDRRX: Update on First Quarter Financials (NASDAQ:PTIE)
finance.yahoo.com - May 6 at 11:50 AM
equities.com logoPain Therapeutics (PTIE) Drops 6.45% on May 04 - Equities.com (NASDAQ:PTIE)
www.equities.com - May 5 at 10:46 PM
globenewswire.com logoPain Therapeutics Reports Q1 2016 Financial Results - GlobeNewswire (press release) (NASDAQ:PTIE)
globenewswire.com - May 5 at 10:46 PM
sg.finance.yahoo.com logoPain Therapeutics reports 1Q loss (NASDAQ:PTIE)
sg.finance.yahoo.com - May 5 at 7:01 PM
publicnow.com logoPain Therapeutics Reports Q1 2016 Financial Results (NASDAQ:PTIE)
www.publicnow.com - May 5 at 4:21 PM
biz.yahoo.com logoPAIN THERAPEUTICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh (NASDAQ:PTIE)
biz.yahoo.com - May 5 at 4:10 PM
News IconPain Therapeutics, Inc. (NASDAQ:PTIE)'s Company Shares Increased 19.51% After High Volatility - B.O.D.Y Confidential (NASDAQ:PTIE)
www.bodyconfidential.com - April 25 at 6:16 PM
kcregister.com logoMarket Movers: Alcoa Inc. (NYSE:AA), Pain Therapeutics Inc. (NASDAQ:PTIE), First Commonwealth Financial Corp ... - KC Register (NASDAQ:PTIE)
www.kcregister.com - April 25 at 6:16 PM
News IconWhat's Ahead for Pain Therapeutics, Inc. After Today's Huge Increase? - The Post (NASDAQ:PTIE)
www.bibeypost.com - April 24 at 3:33 AM
equities.com logoPain Therapeutics (PTIE) Jumps 5.1% on April 22 - Equities.com (NASDAQ:PTIE)
www.equities.com - April 22 at 10:47 PM
istreetwire.com logoStocks Roundup: Silver Standard Resources (SSRI), Pain Therapeutics (PTIE), Cymabay Therapeutics (CBAY) - iStreetWire (NASDAQ:PTIE)
www.istreetwire.com - April 22 at 5:41 PM
istreetwire.com logoStocks Roundup: Pain Therapeutics Inc. (PTIE), Cymabay Therapeutics, Inc. (CBAY), Silver Standard Resources Inc ... - iStreetWire (NASDAQ:PTIE)
www.istreetwire.com - April 22 at 5:41 PM
benzinga.com logo10 Stocks Moving In Wednesday's Pre-Market Session - Benzinga (NASDAQ:PTIE)
www.benzinga.com - April 13 at 5:37 PM
benzinga.com logoPain Therapeutics Gains 7%, FDA Has Accepted Company's Remoxy For Review - Benzinga (NASDAQ:PTIE)
www.benzinga.com - April 13 at 5:37 PM
News IconDrug Pricing, Presidential Politics, and Three Biotechs with Promise (NASDAQ:PTIE)
www.investorideas.com - April 13 at 5:37 PM

Social

Pain Therapeutics (NASDAQ:PTIE) Chart for Sunday, September, 25, 2016


Last Updated on 9/25/2016 by MarketBeat.com Staff